{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:29:03Z","timestamp":1791584943422,"version":"4.3.4"},"reference-count":179,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62164001"],"award-info":[{"award-number":["62164001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702985"],"award-info":[{"award-number":["81702985"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360599"],"award-info":[{"award-number":["82360599"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020784","name":"Gannan Medical University","doi-asserted-by":"publisher","award":["QD202304"],"award-info":[{"award-number":["QD202304"]}],"id":[{"id":"10.13039\/501100020784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20212ACB206001"],"award-info":[{"award-number":["20212ACB206001"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20232BAB206121"],"award-info":[{"award-number":["20232BAB206121"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intimp.2025.115734","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:32:07Z","timestamp":1761946327000},"page":"115734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P1","title":["Small-molecule therapies targeting tumor-associated macrophages in glioma: mechanisms and potential"],"prefix":"10.1016","volume":"168","author":[{"given":"Hua","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Ockleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renhui","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaochun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.intimp.2025.115734_bb0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41582-022-00679-w","article-title":"Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours","volume":"18","author":"Horbinski","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115734_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9030324","article-title":"Current FDA-approved therapies for high-grade malignant gliomas","volume":"9","author":"Fisher","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.intimp.2025.115734_bb0015","first-page":"166","article-title":"Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma","volume":"60","author":"Van Meir","year":"2010","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.intimp.2025.115734_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.350","article-title":"Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment","volume":"4","author":"Sui","year":"2013","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.intimp.2025.115734_bb0025","doi-asserted-by":"crossref","DOI":"10.1111\/nan.13016","article-title":"Microglia induce an interferon-stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide","volume":"50","author":"S\u00f8rensen","year":"2024","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.intimp.2025.115734_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102029","article-title":"How did lomustine become standard of care in recurrent glioblastoma?","volume":"87","author":"Weller","year":"2020","journal-title":"Cancer Treat. Rev."},{"issue":"8","key":"10.1016\/j.intimp.2025.115734_bb0035","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1634\/theoncologist.2009-0317","article-title":"Bevacizumab","volume":"15","author":"Kazazi-Hyseni","year":"2010","journal-title":"Oncologist"},{"issue":"8","key":"10.1016\/j.intimp.2025.115734_bb0040","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2174\/138945010791591395","article-title":"Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy","volume":"11","author":"Niu","year":"2010","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00391598","article-title":"H2-antagonists and carmustine","volume":"115","author":"Dorr","year":"1989","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115734_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113277","article-title":"Propofol enhances the sensitivity of glioblastoma cells to temozolomide by inhibiting macrophage activation in tumor microenvironment to down-regulate HIF-1\u03b1 expression","volume":"418","author":"Zhao","year":"2022","journal-title":"Exp. Cell Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.115734_bb0055","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3171\/jns.1979.50.3.0305","article-title":"Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors","volume":"50","author":"Morantz","year":"1979","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nn.4185","article-title":"The role of microglia and macrophages in glioma maintenance and progression","volume":"19","author":"Hambardzumyan","year":"2016","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.intimp.2025.115734_bb0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/0973-1482.25847","article-title":"Dendritic cells heterogeneity and its role in cancer immunity","volume":"2","author":"Lin","year":"2006","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.intimp.2025.115734_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101481","article-title":"The role of dendritic cells in cancer and anti-tumor immunity","volume":"52","author":"Marciscano","year":"2021","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00018-024-05497-5","article-title":"Activated kynurenine pathway metabolism by YKL-40 establishes an inhibitory immune microenvironment and drives glioblastoma development","volume":"82","author":"Chen","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13045-021-01187-y","article-title":"Neutrophils in cancer carcinogenesis and metastasis","volume":"14","author":"Xiong","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0085","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/imr.12447","article-title":"Priming of the neutrophil respiratory burst: role in host defense and inflammation","volume":"273","author":"El-Benna","year":"2016","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.intimp.2025.115734_bb0090","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.trecan.2022.04.010","article-title":"Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma","volume":"8","author":"Pang","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.intimp.2025.115734_bb0095","article-title":"Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115734_bb0100","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","article-title":"Clinical relevance of tumour-associated macrophages","volume":"19","author":"Pittet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115734_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030689","article-title":"Revealing and harnessing tumour-associated microglia\/macrophage heterogeneity in glioblastoma","volume":"21","author":"Pires-Afonso","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13059-017-1362-4","article-title":"Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment","volume":"18","author":"M\u00fcller","year":"2017","journal-title":"Genome Biol."},{"issue":"14","key":"10.1016\/j.intimp.2025.115734_bb0115","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1158\/1078-0432.CCR-18-1627","article-title":"Brain tumor microenvironment and host state: implications for immunotherapy","volume":"25","author":"Tomaszewski","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2025.115734_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104239","article-title":"Integrated single-cell transcriptomic analyses reveal that GPNMB-high macrophages promote PN-MES transition and impede T cell activation in GBM","volume":"83","author":"Xiong","year":"2022","journal-title":"EBioMedicine"},{"issue":"17","key":"10.1016\/j.intimp.2025.115734_bb0125","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1158\/1078-0432.CCR-17-1846","article-title":"T-cell exhaustion signatures vary with tumor type and are severe in glioblastoma","volume":"24","author":"Woroniecka","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.115734_bb0130","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41591-019-0349-y","article-title":"Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma","volume":"25","author":"Zhao","year":"2019","journal-title":"Nat. Med."},{"issue":"Pt A","key":"10.1016\/j.intimp.2025.115734_bb0135","article-title":"Quantitative analysis of immune cells within the tumor microenvironment of glioblastoma and their relevance for prognosis","volume":"142","author":"Wang","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115734_bb0140","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11684-018-0657-5","article-title":"Activation of phagocytosis by immune checkpoint blockade","volume":"12","author":"Li","year":"2018","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.115734_bb0145","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.intimp.2025.115734_bb0150","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169314","article-title":"Immune checkpoint blockade induces distinct alterations in the microenvironments of primary and metastatic brain tumors","volume":"133","author":"Sun","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0155","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2425124","article-title":"Markers of tumor-associated macrophages and microglia exhibit high intratumoral heterogeneity in human glioblastoma tissue","volume":"13","author":"Ispirjan","year":"2024","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.intimp.2025.115734_bb0160","first-page":"1534","article-title":"Co-expression of immune checkpoints in glioblastoma revealed by single-nucleus RNA sequencing and spatial transcriptomics, Comput Struct","volume":"23","author":"Yuan","year":"2024","journal-title":"Biotechnol. J."},{"issue":"41","key":"10.1016\/j.intimp.2025.115734_bb0165","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000039836","article-title":"Identification of prognostic biomarkers related to retinoic acid metabolism in gliomas and analysis of their impact on the immune microenvironment","volume":"103","author":"Xu","year":"2024","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.intimp.2025.115734_bb0170","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009210","article-title":"NKG2C\/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma","volume":"12","author":"de Dios","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"14","key":"10.1016\/j.intimp.2025.115734_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411759","article-title":"The clinical significance of CD73 in cancer","volume":"24","author":"Bach","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"34","key":"10.1016\/j.intimp.2025.115734_bb0180","doi-asserted-by":"crossref","first-page":"23001","DOI":"10.1021\/acsnano.4c04553","article-title":"Boost infiltration and activity of T cells via inhibiting ecto-5\u2032-nucleotidase (CD73) immune checkpoint to enhance glioblastoma immunotherapy","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41591-019-0694-x","article-title":"Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma","volume":"26","author":"Goswami","year":"2020","journal-title":"Nat. Med."},{"issue":"14","key":"10.1016\/j.intimp.2025.115734_bb0190","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMe2401307","article-title":"CAR T-cell therapy for glioblastoma","volume":"390","author":"Jenkins","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.115734_bb0195","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ccell.2022.12.007","article-title":"MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors","volume":"41","author":"Kilian","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0200","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1172\/JCI121266","article-title":"Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target","volume":"129","author":"Wei","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2025.115734_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216380","article-title":"Noninvasive radiomics model reveals macrophage infiltration in glioma","volume":"573","author":"Fan","year":"2023","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.intimp.2025.115734_bb0210","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","article-title":"Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization","volume":"24","author":"Pombo Antunes","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2025.115734_bb0215","doi-asserted-by":"crossref","unstructured":"S. D. Jayasingam, M. Citartan, T. H. Thang, A. A. Mat Zin, K. C. Ang, E. S. Ch'ng, Evaluating the polarization of tumor-associated macrophages into M1 and M2 phenotypes in human cancer tissue: technicalities and challenges in routine clinical practice, Front. Oncol. 9 (2019) 1512,Doi: https:\/\/doi.org\/10.3389\/fonc.2019.01512.","DOI":"10.3389\/fonc.2019.01512"},{"key":"10.1016\/j.intimp.2025.115734_bb0220","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev-immunol-020711-075008","article-title":"Cancer and inflammation: an old intuition with rapidly evolving new concepts","volume":"30","author":"Trinchieri","year":"2012","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115734_bb0225","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2025.115734_bb0230","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3389\/fimmu.2020.01731","article-title":"Redefining tumor-associated macrophage subpopulations and functions in the tumor microenvironment","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115734_bb0235","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115734_bb0240","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/cmi.2017.107","article-title":"The unique structural and functional features of CXCL12","volume":"15","author":"Janssens","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115734_bb0245","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41419-024-06784-6","article-title":"CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0250","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/neuonc\/not149","article-title":"Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats","volume":"16","author":"Liu","year":"2014","journal-title":"Neuro Oncol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115734_bb0255","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00018-023-05032-y","article-title":"Disruption of cholangiocyte-B cell crosstalk by blocking the CXCL12-CXCR4 axis alleviates liver fibrosis","volume":"80","author":"Zhang","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0260","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-022-01292-5","article-title":"Bifunctional small molecules targeting PD-L1\/CXCL12 as dual immunotherapy for cancer treatment","volume":"8","author":"Cheng","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1180","key":"10.1016\/j.intimp.2025.115734_bb0265","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/postmj\/qgad102","article-title":"Aitongping patch could alleviate cancer pain via suppressing microglia activation and modulating the miR-150-5p\/CXCL12 signaling","volume":"100","author":"Chen","year":"2024","journal-title":"Postgrad. Med. J."},{"issue":"13","key":"10.1016\/j.intimp.2025.115734_bb0270","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1158\/1078-0432.CCR-21-2830","article-title":"CXCL14 promotes a robust brain tumor-associated immune response in glioma","volume":"28","author":"Kumar","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.intimp.2025.115734_bb0275","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004452","article-title":"LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization","volume":"10","author":"Hu","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"22","key":"10.1016\/j.intimp.2025.115734_bb0280","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1158\/0008-5472.CAN-23-3878","article-title":"Galectin-9 mediates the functions of microglia in the hypoxic brain tumor microenvironment","volume":"84","author":"Lee","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2025.115734_bb0285","doi-asserted-by":"crossref","unstructured":"L. Finotto, B. Cole, W. Giese, E. Baumann, A. Claeys, M. Vanmechelen, B. Decraene, M. Derweduwe, N. Dubroja Lakic, G. Shankar, M. Nagathihalli Kantharaju, J. P. Albrecht, I. Geudens, F. Stanchi, K. L. Ligon, B. Boeckx, D. Lambrechts, K. Harrington, L. Van Den Bosch, S. De Vleeschouwer, F. De Smet, H. Gerhardt, Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastoma, EMBO Mol. Med. 15 (11) (2023) e18144,Doi: 10.15252\/emmm.202318144.","DOI":"10.15252\/emmm.202318144"},{"issue":"4","key":"10.1016\/j.intimp.2025.115734_bb0290","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-023-00636-2","article-title":"Targeting galectin-driven regulatory circuits in cancer and fibrosis","volume":"22","author":"Mari\u00f1o","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0295","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1038\/s41467-022-34001-5","article-title":"Blood monocyte-derived CD169(+) macrophages contribute to antitumor immunity against glioblastoma","volume":"13","author":"Kim","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115734_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216879","article-title":"Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth","volume":"591","author":"Rivera-Ramos","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0305","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40478-024-01754-7","article-title":"Tumor associated microglia\/macrophages utilize GPNMB to promote tumor growth and alter immune cell infiltration in glioma","volume":"12","author":"Yalcin","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.intimp.2025.115734_bb0310","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/bmb\/65.1.121","article-title":"Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain","volume":"65","author":"Banati","year":"2003","journal-title":"Br. Med. Bull."},{"issue":"6005","key":"10.1016\/j.intimp.2025.115734_bb0315","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1194637","article-title":"Fate mapping analysis reveals that adult microglia derive from primitive macrophages","volume":"330","author":"Ginhoux","year":"2010","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.intimp.2025.115734_bb0320","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","article-title":"Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells","volume":"181","author":"Klemm","year":"2020","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.intimp.2025.115734_bb0325","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.3337","article-title":"CSF-1R inhibition alters macrophage polarization and blocks glioma progression","volume":"19","author":"Pyonteck","year":"2013","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.intimp.2025.115734_bb0330","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/ijc.29234","article-title":"PDGFR-\u03b2-activated ACK1-AKT signaling promotes glioma tumorigenesis","volume":"136","author":"Zhang","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2025.115734_bb0335","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.isci.2018.10.011","article-title":"Microglia induce PDGFRB expression in glioma cells to enhance their migratory capacity","volume":"9","author":"Wallmann","year":"2018","journal-title":"iScience"},{"issue":"9","key":"10.1016\/j.intimp.2025.115734_bb0340","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1093\/brain\/awac222","article-title":"Astrocyte immunometabolic regulation of the tumour microenvironment drives glioblastoma pathogenicity","volume":"145","author":"Perelroizen","year":"2022","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.intimp.2025.115734_bb0345","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/neuonc\/nox165","article-title":"Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment","volume":"20","author":"Szulzewsky","year":"2018","journal-title":"Neuro Oncol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115734_bb0350","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.jid.2020.02.023","article-title":"Pivotal involvement of the CX3CL1-CX3CR1 axis for the recruitment of M2 tumor-associated macrophages in skin carcinogenesis","volume":"140","author":"Ishida","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2025.115734_bb0355","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","article-title":"Progress in tumor-associated macrophage (TAM)-targeted therapeutics","volume":"114","author":"Ngambenjawong","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2025.115734_bb0360","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ncb3090","article-title":"Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth","volume":"17","author":"Zhou","year":"2015","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115734_bb0365","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/2159-8290.CD-19-0400","article-title":"Circadian regulator CLOCK recruits immune-suppressive microglia into the GBM tumor microenvironment","volume":"10","author":"Chen","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2025.115734_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112187","article-title":"Silencing BMAL1 promotes M1\/M2 polarization through the LDHA\/lactate axis to promote GBM sensitivity to bevacizumab","volume":"134","author":"Wang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115734_bb0375","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jconrel.2024.12.059","article-title":"Microglia membrane-mediated trans-blood-brain barrier prodrug micelles enhance phagocytosis for glioblastoma chemo-immunotherapy","volume":"378","author":"Li","year":"2025","journal-title":"J. Control. Release"},{"issue":"22","key":"10.1016\/j.intimp.2025.115734_bb0380","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178628","article-title":"Dual targeting macrophages and microglia is a therapeutic vulnerability in models of PTEN-deficient glioblastoma","volume":"134","author":"Liu","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.intimp.2025.115734_bb0385","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1158\/2159-8290.CD-22-0455","article-title":"Targeting microglial metabolic rewiring synergizes with immune-checkpoint blockade therapy for glioblastoma","volume":"13","author":"Ye","year":"2023","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.intimp.2025.115734_bb0390","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/neuonc\/nop023","article-title":"Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties","volume":"12","author":"Rodrigues","year":"2010","journal-title":"Neuro Oncol."},{"issue":"7948","key":"10.1016\/j.intimp.2025.115734_bb0395","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-022-05680-3","article-title":"Single-cell spatial immune landscapes of primary and metastatic brain tumours","volume":"614","author":"Karimi","year":"2023","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.intimp.2025.115734_bb0400","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1158\/0008-5472.CAN-16-2310","article-title":"Cellular and molecular identity of tumor-associated macrophages in glioblastoma","volume":"77","author":"Chen","year":"2017","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/j.intimp.2025.115734_bb0405","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1016\/j.cell.2024.07.030","article-title":"Macrophage-mediated myelin recycling fuels brain cancer malignancy","volume":"187","author":"Kloosterman","year":"2024","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.intimp.2025.115734_bb0410","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1158\/0008-5472.CAN-24-3362","article-title":"Lipid-laden macrophages recycle myelin to feed glioblastoma","volume":"84","author":"Pang","year":"2024","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.intimp.2025.115734_bb0415","article-title":"Hypoxia-driven protease legumain promotes immunosuppression in glioblastoma","volume":"4","author":"Pang","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"11","key":"10.1016\/j.intimp.2025.115734_bb0420","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1111\/cns.14269","article-title":"scRNA-seq and proteomics reveal the distinction of M2-like macrophages between primary and recurrent malignant glioma and its critical role in the recurrence","volume":"29","author":"You","year":"2023","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0425","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s12672-024-01391-5","article-title":"Exploring the significance and potential mechanisms of hippo pathway-associated genes in prognosis of glioma patients","volume":"15","author":"Liu","year":"2024","journal-title":"Discov. Oncol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115734_bb0430","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1002\/tox.24259","article-title":"PTPN7 mediates macrophage-polarization and determines immunotherapy in gliomas: A single-cell sequencing analysis","volume":"39","author":"Ji","year":"2024","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.intimp.2025.115734_bb0435","article-title":"TREM2 is associated with tumor immunity and implies poor prognosis in glioma","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115734_bb0440","article-title":"IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy","volume":"14","author":"Ye","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115734_bb0445","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.ccell.2024.03.013","article-title":"Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization","volume":"42","author":"Wang","year":"2024","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.intimp.2025.115734_bb0450","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1158\/1078-0432.CCR-23-0430","article-title":"Hypoxia-induced neuronal activity in glioma patients polarizes microglia by potentiating RNA m6A demethylation","volume":"30","author":"Guo","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0455","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41467-023-37170-z","article-title":"Quinolinate promotes macrophage-induced immune tolerance in glioblastoma through the NMDAR\/PPAR\u03b3 signaling axis","volume":"14","author":"Kesarwani","year":"2023","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.intimp.2025.115734_bb0460","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1158\/2159-8290.CD-22-0196","article-title":"Natural coevolution of tumor and immunoenvironment in glioblastoma","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov."},{"issue":"18","key":"10.1016\/j.intimp.2025.115734_bb0465","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204621120","article-title":"Self-assembling paclitaxel-mediated stimulation of tumor-associated macrophages for postoperative treatment of glioblastoma","volume":"120","author":"Wang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0470","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13046-024-03144-2","article-title":"Progesterone boosts abiraterone-driven target and NK cell therapies against glioblastoma","volume":"43","author":"Chen","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2025.115734_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113738","article-title":"Clofazimine enhances anti-glioma effect of immunotherapy","volume":"145","author":"Kosianova","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115734_bb0480","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41556-024-01428-5","article-title":"Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma","volume":"26","author":"Wu","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115734_bb0485","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41419-024-06971-5","article-title":"Astrocytes and the tumor microenvironment inflammatory state dictate the killing of glioblastoma cells by Smac mimetic compounds","volume":"15","author":"Malone","year":"2024","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.intimp.2025.115734_bb0490","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ccell.2019.05.003","article-title":"Symbiotic macrophage-glioma cell interactions reveal synthetic lethality in PTEN-null glioma","volume":"35","author":"Chen","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2025.115734_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110109","article-title":"Deguelin inhibits the glioblastoma progression through suppressing CCL2\/NF\u03baB signaling pathway","volume":"259","author":"Qian","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2025.115734_bb0500","doi-asserted-by":"crossref","unstructured":"S. Liu, X. Cai, J. Wu, Q. Cong, X. Chen, T. Li, F. Du, J. Ren, Y. T. Wu, N. V. Grishin, Z. J. Chen, Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation, Science 347 (6227) (2015) aaa2630,Doi: https:\/\/doi.org\/10.1126\/science.aaa2630.","DOI":"10.1126\/science.aaa2630"},{"issue":"12","key":"10.1016\/j.intimp.2025.115734_bb0505","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.7150\/thno.73104","article-title":"Co-delivery of phagocytosis checkpoint and STING agonist by a Trojan horse nanocapsule for orthotopic glioma immunotherapy","volume":"12","author":"Zhou","year":"2022","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.intimp.2025.115734_bb0510","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175033","article-title":"STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma","volume":"134","author":"Najem","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2025.115734_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117074","article-title":"\u03b2-Mangostin targets and suppresses glioma via STING activation and tumor-associated microglia polarization","volume":"177","author":"Yang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.intimp.2025.115734_bb0520","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.immuni.2018.07.008","article-title":"Non-canonical NF-\u03baB antagonizes STING sensor-mediated DNA sensing in radiotherapy","volume":"49","author":"Hou","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.115734_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155417","article-title":"Dioscin decreases M2 polarization via inhibiting a positive feedback loop between RBM47 and NF-\u03baB in glioma","volume":"128","author":"Bai","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2025.115734_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155611","article-title":"Effect of luteolin on glioblastoma's immune microenvironment and tumor growth suppression","volume":"130","author":"Zong","year":"2024","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.intimp.2025.115734_bb0535","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22230","article-title":"Inhibition of the TCF12\/VSIG4 axis by palbociclib diminishes the proliferation and migration of glioma cells and decreases the M2 polarization of glioma-associated microglia","volume":"85","author":"Li","year":"2024","journal-title":"Drug Dev. Res."},{"issue":"6","key":"10.1016\/j.intimp.2025.115734_bb0540","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1158\/1078-0432.CCR-23-3322","article-title":"Levetiracetam: a potent sword against microglia polarization in gliomas","volume":"30","author":"Cui","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"Pt 1","key":"10.1016\/j.intimp.2025.115734_bb0545","article-title":"Extract of Astragali Radix and Solanum nigrum Linne regulates microglia and macrophage polarization and inhibits the growth and infiltration of C6 glioblastoma","volume":"319","author":"Shen","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115734_bb0550","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.ccell.2024.08.012","article-title":"Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence","volume":"42","author":"Watson","year":"2024","journal-title":"Cancer Cell"},{"issue":"22","key":"10.1016\/j.intimp.2025.115734_bb0555","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1158\/1078-0432.CCR-23-0576","article-title":"Effective reprogramming of patient-derived M2-polarized glioblastoma-associated microglia\/macrophages by treatment with GW2580","volume":"29","author":"Fermi","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2025.115734_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156271","article-title":"Ginsenoside RK3 inhibits glioblastoma by modulating macrophage M2 polarization via the PPARG\/CCL2 axis","volume":"136","author":"Zhang","year":"2025","journal-title":"Phytomedicine"},{"issue":"9","key":"10.1016\/j.intimp.2025.115734_bb0565","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41419-024-07056-z","article-title":"SMAC mimetic drives microglia phenotype and glioblastoma immune microenvironment","volume":"15","author":"Snacel-Fazy","year":"2024","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.intimp.2025.115734_bb0570","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/neuonc\/noae177","article-title":"Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma","volume":"26","author":"Duerinck","year":"2024","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0575","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7150\/ijbs.83599","article-title":"Cancer differentiation inducer chlorogenic acid suppresses PD-L1 expression and boosts antitumor immunity of PD-1 antibody","volume":"20","author":"Li","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2025.115734_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176274","article-title":"Metformin-induced reduction of CCR8 enhances the anti-tumor immune response of PD-1 immunotherapy in glioblastoma","volume":"964","author":"Li","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2025.115734_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111178","article-title":"Cordycepin inhibits glioma growth by downregulating PD-L1 expression via the NOD-like receptor\/NFKB1\/STAT1 axis","volume":"400","author":"Chen","year":"2024","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0590","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s41065-024-00349-5","article-title":"Atorvastatin inhibits glioma glycolysis and immune escape by modulating the miR-125a-5p\/TXLNA axis","volume":"161","author":"Gao","year":"2024","journal-title":"Hereditas"},{"key":"10.1016\/j.intimp.2025.115734_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2022.106067","article-title":"Allopregnanolone suppresses glioblastoma survival through decreasing DPYSL3 and S100A11 expression","volume":"219","author":"Feng","year":"2022","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"683","key":"10.1016\/j.intimp.2025.115734_bb0600","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq3558","article-title":"Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy","volume":"15","author":"Yang","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"28","key":"10.1016\/j.intimp.2025.115734_bb0605","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111003119","article-title":"STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models","volume":"119","author":"Berger","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2025.115734_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216480","article-title":"STING activation counters glioblastoma by vascular alteration and immune surveillance","volume":"579","author":"Joseph","year":"2023","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.intimp.2025.115734_bb0615","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14791","article-title":"Targeting MS4A4A: A novel pathway to improve immunotherapy responses in glioblastoma","volume":"30","author":"Shao","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2025.115734_bb0620","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/15548627.2018.1556946","article-title":"TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia","volume":"15","author":"Lee","year":"2019","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0625","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/neuonc\/noae167","article-title":"Toll-like receptor agonists promote the formation of tertiary lymphoid structure and improve anti-glioma immunity","volume":"27","author":"Shen","year":"2025","journal-title":"Neuro Oncol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115734_bb0630","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70124","article-title":"Olaparib enhances the efficacy of third-generation oncolytic adenoviruses against glioblastoma by modulating DNA damage response and p66shc-induced apoptosis","volume":"30","author":"Liu","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2025.115734_bb0635","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/15548627.2018.1522467","article-title":"Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1","volume":"15","author":"Li","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.intimp.2025.115734_bb0640","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.phrs.2016.05.004","article-title":"A cell-based quantitative high-throughput image screening identified novel autophagy modulators","volume":"110","author":"Li","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"23","key":"10.1016\/j.intimp.2025.115734_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e40806","article-title":"CB2R activation enhances tumor-associated macrophages-mediated phagocytosis of glioma cell","volume":"10","author":"Lu","year":"2024","journal-title":"Heliyon"},{"issue":"11","key":"10.1016\/j.intimp.2025.115734_bb0650","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s43018-021-00267-9","article-title":"Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cells","volume":"2","author":"Zhai","year":"2021","journal-title":"Nat. Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2025.115734_bb0655","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1158\/0008-5472.CAN-08-1166","article-title":"Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism","volume":"69","author":"Kaur","year":"2009","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.intimp.2025.115734_bb0660","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1038\/s44318-024-00130-4","article-title":"LC3-associated phagocytosis of neutrophils triggers tumor ferroptotic cell death in glioblastoma","volume":"43","author":"Lu","year":"2024","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0665","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1021\/acsnano.4c13388","article-title":"Magnesium-phenolic nanoeditor refining gliomatous T cells for metalloimmunotherapy","volume":"19","author":"Li","year":"2025","journal-title":"ACS Nano"},{"issue":"23","key":"10.1016\/j.intimp.2025.115734_bb0670","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312787","article-title":"Combining antimiR-25 and cGAMP nanocomplexes enhances immune responses via M2 macrophage reprogramming","volume":"25","author":"Petrovic","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2025.115734_bb0675","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1021\/acs.molpharmaceut.4c00875","article-title":"Polyinosinic\/polycytidylic lipid nanoparticles enhance immune cell infiltration and improve survival in the glioblastoma mouse model","volume":"21","author":"Br\u00fc\u00dfeler","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.intimp.2025.115734_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122688","article-title":"CD40 agonist engineered immunosomes modulated tumor microenvironment and showed pro-immunogenic response, reduced toxicity, and tumor free survival in mice bearing glioblastoma","volume":"311","author":"Gaur","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.intimp.2025.115734_bb0685","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2024.02.004","article-title":"Biomimetic nano-chelate diethyldithiocarbamate Cu\/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy","volume":"368","author":"Wang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2025.115734_bb0690","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.2147\/IJN.S440405","article-title":"Synergistically enhancing immunotherapy efficacy in glioblastoma with gold-core silica-shell nanoparticles and radiation","volume":"18","author":"Chen","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"30","key":"10.1016\/j.intimp.2025.115734_bb0695","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301861","article-title":"Enhancement of microglia functions by developed nano-immuno-synergist to ameliorate immunodeficiency for malignant glioma treatment","volume":"12","author":"Xu","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0700","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41467-023-36321-6","article-title":"T cell-independent eradication of experimental glioma by intravenous TLR7\/8-agonist-loaded nanoparticles","volume":"14","author":"Turco","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.115734_bb0705","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.actbio.2022.11.013","article-title":"A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated siRNA delivery for glioma immunotherapy via intranasal administration","volume":"155","author":"Tang","year":"2023","journal-title":"Acta Biomater."},{"issue":"12","key":"10.1016\/j.intimp.2025.115734_bb0710","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41565-022-01225-x","article-title":"Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration","volume":"17","author":"Yang","year":"2022","journal-title":"Nat. Nanotechnol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115734_bb0715","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1093\/neuonc\/noae135","article-title":"Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood-brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas","volume":"26","author":"Kim","year":"2024","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0720","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1038\/s41467-024-48326-w","article-title":"Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas","volume":"15","author":"Arrieta","year":"2024","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.intimp.2025.115734_bb0725","doi-asserted-by":"crossref","first-page":"27187","DOI":"10.1021\/acsami.4c05831","article-title":"Biomimetic dual-target theranostic nanovaccine enables magnetic resonance imaging and chemo\/chemodynamic\/immune therapy of glioma","volume":"16","author":"Huang","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.intimp.2025.115734_bb0730","article-title":"Enhancing glioma-specific drug delivery through self-assembly of macrophage membrane and targeted polymer assisted by low-frequency ultrasound irradiation","volume":"26","author":"Lin","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.intimp.2025.115734_bb0735","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jconrel.2024.04.043","article-title":"Effective glioblastoma immune sonodynamic treatment mediated by macrophage cell membrane cloaked biomimetic nanomedicines","volume":"370","author":"Shan","year":"2024","journal-title":"J. Control. Release"},{"issue":"18","key":"10.1016\/j.intimp.2025.115734_bb0740","article-title":"Metabolism\/immunity dual-regulation thermogels potentiating immunotherapy of glioblastoma through lactate-excretion inhibition and PD-1\/PD-L1 blockade","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"14","key":"10.1016\/j.intimp.2025.115734_bb0745","doi-asserted-by":"crossref","first-page":"17627","DOI":"10.1021\/acsami.3c00468","article-title":"Immunostimulant in situ fibrin gel for post-operative glioblastoma treatment by macrophage reprogramming and photo-chemo-immunotherapy","volume":"15","author":"Zhang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.intimp.2025.115734_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122006","article-title":"Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival","volume":"294","author":"Catania","year":"2023","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.intimp.2025.115734_bb0755","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr8841","article-title":"Peptide-drug conjugates repolarize glioblastoma-associated macrophages to resensitize chemo-immunotherapy of glioblastoma","volume":"11","author":"Li","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0760","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11060-023-04257-y","article-title":"T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma","volume":"162","author":"Li","year":"2023","journal-title":"J. Neurooncol"},{"issue":"4","key":"10.1016\/j.intimp.2025.115734_bb0765","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008880","article-title":"Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival","volume":"12","author":"Bommareddy","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"17","key":"10.1016\/j.intimp.2025.115734_bb0770","doi-asserted-by":"crossref","first-page":"11165","DOI":"10.1021\/acsnano.4c00050","article-title":"Enhancing glioblastoma immunotherapy with integrated chimeric antigen receptor T cells through the re-education of tumor-associated microglia and macrophages","volume":"18","author":"Zhu","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0775","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12951-023-01810-9","article-title":"Convection-enhanced delivery of nanoencapsulated gene locoregionally yielding ErbB2\/Her2-specific CAR-macrophages for brainstem glioma immunotherapy","volume":"21","author":"Gao","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115734_bb0780","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncb3124","article-title":"Metabolic pathways promoting cancer cell survival and growth","volume":"17","author":"Boroughs","year":"2015","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115734_bb0785","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"issue":"3495","key":"10.1016\/j.intimp.2025.115734_bb0790","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1126\/science.134.3495.2041","article-title":"Toxohormone-like factor from microorganisms with impaired respiration","volume":"134","author":"Callao","year":"1961","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.intimp.2025.115734_bb0795","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","article-title":"Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of I\u03baB\u03b1","volume":"34","author":"Guo","year":"2022","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0800","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12967-025-06202-1","article-title":"ZNRF2 is essential for gliomagenesis through orchestrating glycolysis and acts as a promising therapeutic target in glioma","volume":"23","author":"Xi","year":"2025","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.115734_bb0805","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202404782","article-title":"Biomimetic membrane vesicles reprogram microglia polarization and remodel the immunosuppressive microenvironment of glioblastoma via PERK\/HIF-1\u03b1\/glycolysis pathway","volume":"14","author":"Guo","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"4","key":"10.1016\/j.intimp.2025.115734_bb0810","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cmet.2018.03.008","article-title":"The science and translation of lactate shuttle theory","volume":"27","author":"Brooks","year":"2018","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0815","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13046-024-03025-8","article-title":"GPR65 sensing tumor-derived lactate induces HMGB1 release from TAM via the cAMP\/PKA\/CREB pathway to promote glioma progression","volume":"43","author":"Yan","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.intimp.2025.115734_bb0820","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176851","article-title":"Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation","volume":"134","author":"Wang","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"40","key":"10.1016\/j.intimp.2025.115734_bb0825","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1038\/s41388-022-02445-0","article-title":"Dual role of pseudogene TMEM198B in promoting lipid metabolism and immune escape of glioma cells","volume":"41","author":"Zhan","year":"2022","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.intimp.2025.115734_bb0830","first-page":"282","article-title":"Diet and nutrition: nutrition and resistance to disease","volume":"40","author":"Robertson","year":"1939","journal-title":"Can. Med. Assoc. J."},{"issue":"7962","key":"10.1016\/j.intimp.2025.115734_bb0835","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41586-023-06061-0","article-title":"Lysine catabolism reprograms tumour immunity through histone crotonylation","volume":"617","author":"Yuan","year":"2023","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.intimp.2025.115734_bb0840","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1001\/jamaoncol.2017.0184","article-title":"HER2-specific chimeric antigen receptor-modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial","volume":"3","author":"Ahmed","year":"2017","journal-title":"JAMA Oncol."},{"issue":"8","key":"10.1016\/j.intimp.2025.115734_bb0845","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.ccell.2024.07.002","article-title":"CAR T cell combination therapies to treat cancer","volume":"42","author":"Uslu","year":"2024","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.intimp.2025.115734_bb0850","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.ymthe.2025.03.004","article-title":"CAR T cell therapy for glioblastoma: a review of the first decade of clinical trials","volume":"33","author":"Begley","year":"2025","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0855","doi-asserted-by":"crossref","first-page":"9718","DOI":"10.1038\/s41467-024-54129-w","article-title":"Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRP\u03b3-derived CD47 blocker","volume":"15","author":"Martins","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2025.115734_bb0860","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ymthe.2022.08.021","article-title":"CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma","volume":"31","author":"Wang","year":"2023","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.intimp.2025.115734_bb0865","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/neuonc\/noae126","article-title":"IL-13R\u03b12\/TGF-\u03b2 bispecific CAR-T cells counter TGF-\u03b2-mediated immune suppression and potentiate anti-tumor responses in glioblastoma","volume":"26","author":"Hou","year":"2024","journal-title":"Neuro Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115734_bb0870","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41591-024-02893-z","article-title":"Intrathecal bivalent CAR T cells targeting EGFR and IL13R\u03b12 in recurrent glioblastoma: phase 1 trial interim results","volume":"30","author":"Bagley","year":"2024","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.intimp.2025.115734_bb0875","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/s43018-024-00764-7","article-title":"Targeting TGF\u03b2-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome","volume":"5","author":"Vinnakota","year":"2024","journal-title":"Nat. Cancer"},{"issue":"11","key":"10.1016\/j.intimp.2025.115734_bb0880","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2217\/imt-2021-0054","article-title":"Chimeric antigen receptor macrophage for glioblastoma immunotherapy: the way forward","volume":"13","author":"Gatto","year":"2021","journal-title":"Immunotherapy"},{"issue":"14","key":"10.1016\/j.intimp.2025.115734_bb0885","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.7150\/thno.98290","article-title":"Empowering brain tumor management: chimeric antigen receptor macrophage therapy","volume":"14","author":"Feng","year":"2024","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.intimp.2025.115734_bb0890","article-title":"CAR T cells, CAR NK cells, and CAR macrophages exhibit distinct traits in glioma models but are similarly enhanced when combined with cytokines","volume":"6","author":"Look","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"29","key":"10.1016\/j.intimp.2025.115734_bb0895","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2426724122","article-title":"In vivo generation of CAR macrophages via the enucleated mesenchymal stem cell delivery system for glioblastoma therapy","volume":"122","author":"Zhou","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925017229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925017229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:36:05Z","timestamp":1781897765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925017229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":179,"alternative-id":["S1567576925017229"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115734","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small-molecule therapies targeting tumor-associated macrophages in glioma: mechanisms and potential","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115734","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115734"}}